[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $srpts Sarepta Therapeutics faces scrutiny as social media users discuss potential liver failure risks associated with its viral vector technology. Community engagement is low, but the community is showing signs of growth. ### About $srpts This is a summary of social media activity related to Sarepta Therapeutics, Inc. ($SRPT). ### Insights [#](/topic/$srpts/insights) - $srpts creators is up XXX% from the previous week. - $srpts mentions is up XXXXX% from the previous week. ### Engagements: XXXXX [#](/topic/$srpts/interactions) ---  [Engagements 24-Hour Chart Data](/topic/$srpts/time-series/interactions.tsv) **Current Value**: XXXXX **Daily Average**: XXX **1 Month**: XXXXXX -XX% **1-Year High**: XXXXXX on 2025-05-13 **1-Year Low**: X on 2025-05-24 | Social Network | X | | -------------- | - | | Engagements | XXXXX | ### Mentions: X [#](/topic/$srpts/posts_active) ---  [Mentions 24-Hour Chart Data](/topic/$srpts/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1 Week**: XX +56% **1 Month**: XX +3.30% **1-Year High**: XX on 2025-06-19 **1-Year Low**: X on 2025-05-24 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$srpts/contributors_active) ---  [Creators 24-Hour Chart Data](/topic/$srpts/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $srpts in the last XX hours which is up XX% from X in the previous XX hours **Daily Average**: X **1 Week**: XX +120% **1 Month**: XX +33% **1-Year High**: X on 2025-06-16 **1-Year Low**: X on 2025-05-11 ### Sentiment: % [#](/topic/$srpts/sentiment) ---  [Sentiment 24-Hour Chart Data](/topic/$srpts/time-series/sentiment.tsv) **Top assets mentioned** In the posts about $srpts in the last XX hours [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) **Top topics mentioned** In the posts about $srpts in the last XX hours [voodoo](/topic/voodoo), [$ntlas](/topic/$ntlas), [acquisition](/topic/acquisition), [losses](/topic/losses), [arrowhead](/topic/arrowhead), [has been](/topic/has-been), [cascade](/topic/cascade), [$srpt](/topic/$srpt), [arun](/topic/arun), [protocol](/topic/protocol) ### Top Social Posts [#](/topic/$srpts/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "@JohnCendpts Folks @ Arrowhead must be worried that $srpts tech platform will bring more failures n losses than sucesses in the clinic makes u wonder how much due diligence went into their agreement- just saying" [@djaballh](/creator/x/djaballh) on [X](/post/tweet/1948004422111637759) 2025-07-23 12:57:01 UTC XXX followers, XXX engagements "$srpt's viral vector appears to trigger liver failure in a small subset of patients that led to X deaths. And the 3rd death in the limb girdle is probably related. What immunosuppression regimen can $srpt use to prevent immune cascade Do we have to immunosupress everyone What supporting therapies can we use to prevent acute liver failure if even mild liver enzyme spikes are observed How can we identify which minority of patients will experience serious liver injury The viral vector is the common thread here. It is reasonable that FDA revoked platform designation for $srpt viral vector in" [@aditharun_](/creator/x/aditharun_) on [X](/post/tweet/1947820457685663808) 2025-07-23 00:46:00 UTC XXX followers, XXX engagements "@richtrades100 Which is still nothing compared to say $NTLA's XX% short despite Intellia's functional one-time cure nature versus $SRPT's voodoo uDystrophin" [@FidelisAurelius](/creator/x/FidelisAurelius) on [X](/post/tweet/1947672097741783071) 2025-07-22 14:56:28 UTC XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sarepta Therapeutics faces scrutiny as social media users discuss potential liver failure risks associated with its viral vector technology. Community engagement is low, but the community is showing signs of growth.
This is a summary of social media activity related to Sarepta Therapeutics, Inc. ($SRPT).
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXX
1 Month: XXXXXX -XX%
1-Year High: XXXXXX on 2025-05-13
1-Year Low: X on 2025-05-24
Social Network | X |
---|---|
Engagements | XXXXX |
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: XX +56%
1 Month: XX +3.30%
1-Year High: XX on 2025-06-19
1-Year Low: X on 2025-05-24
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $srpts in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: X
1 Week: XX +120%
1 Month: XX +33%
1-Year High: X on 2025-06-16
1-Year Low: X on 2025-05-11
Top assets mentioned In the posts about $srpts in the last XX hours
Sarepta Therapeutics, Inc. (SRPT)
Top topics mentioned In the posts about $srpts in the last XX hours
voodoo, $ntlas, acquisition, losses, arrowhead, has been, cascade, $srpt, arun, protocol
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@JohnCendpts Folks @ Arrowhead must be worried that $srpts tech platform will bring more failures n losses than sucesses in the clinic makes u wonder how much due diligence went into their agreement- just saying"
@djaballh on X 2025-07-23 12:57:01 UTC XXX followers, XXX engagements
"$srpt's viral vector appears to trigger liver failure in a small subset of patients that led to X deaths. And the 3rd death in the limb girdle is probably related. What immunosuppression regimen can $srpt use to prevent immune cascade Do we have to immunosupress everyone What supporting therapies can we use to prevent acute liver failure if even mild liver enzyme spikes are observed How can we identify which minority of patients will experience serious liver injury The viral vector is the common thread here. It is reasonable that FDA revoked platform designation for $srpt viral vector in"
@aditharun_ on X 2025-07-23 00:46:00 UTC XXX followers, XXX engagements
"@richtrades100 Which is still nothing compared to say $NTLA's XX% short despite Intellia's functional one-time cure nature versus $SRPT's voodoo uDystrophin"
@FidelisAurelius on X 2025-07-22 14:56:28 UTC XXX followers, XXX engagements
/topic/$srpts